PlainRecalls
FDA Drug Moderate Class II Ongoing

Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-946-52

Reported: May 3, 2023 Initiated: March 16, 2023 #D-0548-2023

Product Description

Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-946-52

Reason for Recall

CGMP Deviations

Details

Units Affected
99 bottles
Distribution
Nationwide with the United States
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-946-52. Recalled by Northwind Pharmaceuticals LLC. Units affected: 99 bottles.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on May 3, 2023. Severity: Moderate. Recall number: D-0548-2023.